Leef Brands (LEEEF) Income towards Parent Company (2025 - 2026)
Leef Brands' (LEEEF) quarterly Income towards Parent Company came in at -$426253.0 in Q1 2026, down 260.38% year-on-year from $265776.0 in Q1 2025, and down 260.38% quarter-over-quarter from $265776.0 in Q1 2025.
Leef Brands (LEEEF) Income towards Parent Company (2025 - 2026) Analysis & Trends
Leef Brands has disclosed Income towards Parent Company across 2 years of filings, most recently posting -$426253.0 for Q1 2026.
- Income towards Parent Company for Q1 2026 came in at -$426253.0, down 260.38% year-over-year; the trailing twelve-month figure through Mar 2026 was -$160477.0 (changed N/A YoY), and the FY2025 annual result was -$17.6 million, up 28.77% from the prior year.
- Income towards Parent Company came in at -$426253.0 for Q1 2026 at Leef Brands, down from $265776.0 in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of $265776.0 in Q1 2025 to a low of -$426253.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Leef Brands | - | - | 4.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -426,253.00 |
| Mar 31, 2025 | 265,776.00 |